Lista de obras -

"Controversial issues in climacteric medicine" series 3rd Pisa workshop "HRT in climacteric and aging brain". Pisa, Italy, 15-18 March 2003.

artículo científico publicado en 2003

Clinical relevance of the HERS trial

scientific article published on 01 August 2002

Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome

artículo científico publicado en 2010

Contraception with estradiol valerate and dienogest: adherence to the method.

artículo científico publicado en 2019

Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.

artículo científico publicado en 2005

Dydrogesterone does not reverse the effects of estradiol on endothelium-dependant vasodilation in postmenopausal women: a randomised clinical trial.

artículo científico publicado en 2002

EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis

artículo científico

EMAS position statement: Bone densitometry screening for osteoporosis

artículo científico publicado en 2010

EMAS position statement: Managing menopausal women with a personal or family history of VTE.

artículo científico publicado en 2011

EMAS position statement: Managing the menopause in the context of coronary heart disease

artículo científico publicado en 2010

EMAS position statement: Managing the menopause in women with a past history of endometriosis

artículo científico publicado en 2010

EMAS position statement: Managing women with premature ovarian failure

artículo científico publicado en 2010

EMAS position statement: Vitamin D and postmenopausal health

artículo científico publicado en 2011

EMAS position statement: managing obese postmenopausal women

artículo científico publicado en 2010

EMAS position statement: managing the menopause in women with epilepsy

artículo científico publicado en 2010

Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention

artículo científico publicado en 2007

Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution

artículo científico publicado en 2006

Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women.

artículo científico publicado en 2003

Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women

artículo científico publicado en 2005

Effects of oral contraceptives on bone mineral density.

artículo científico publicado en 2004

Erratum to “EMAS position statement: Bone densitometry screening for osteoporosis” [Maturitas 68 (2011) 98–101]

scholarly article published in Maturitas

Erratum to “EMAS position statement: Managing obese postmenopausal women” [Maturitas 66 (2010) 323–326]

scholarly article published in Maturitas

Erratum to “EMAS position statement: Managing the menopause in the context of coronary heart disease” [Maturitas 68 (2011) 94–97]

scholarly article published in Maturitas

Erratum to “EMAS position statement: Managing the menopause in women with epilepsy” [Maturitas 66 (2010) 327–328]

scholarly article published in Maturitas

Erratum to “EMAS position statement: Managing women with premature ovarian failure” [Maturitas 67 (2010) 91–93]

scholarly article published in Maturitas

From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health

artículo científico publicado en 2006

Homocysteine, menopause and cardiovascular disease

artículo científico publicado en 2007

Hormonal influence on the central nervous system

artículo científico publicado en 2002

Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women

artículo científico publicado en 2009

Hormone replacement therapy and the prevention of postmenopausal osteoporosis

artículo científico publicado en 2014

Hormone therapy

artículo científico publicado en 2003

IMS updated recommendations on postmenopausal hormone therapy

artículo científico publicado en 2007

Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.

artículo científico publicado en 2007

Laser therapy for the restoration of vaginal function

artículo científico publicado en 2017

Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density

artículo científico publicado en 2005

Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists

artículo científico publicado en 2007

Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society

artículo científico publicado en 2017

New HRT options for the treatment of menopausal symptoms and the maintenance of quality of life in postmenopausal women

artículo científico publicado en 2004

Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper

article

Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate

artículo científico publicado en 2002

Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy.

artículo científico publicado en 2003

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

artículo científico publicado en 2010

Practical recommendations for hormone replacement therapy in the peri- and postmenopause

artículo científico publicado en 2004

Progesterone to treat vasomotor symptoms

artículo científico publicado en 2012

Quantitative ultrasound (QUS) of bone in the management of postmenopausal women

artículo científico publicado en 2004

Recommendations on the management of fragility fracture risk in women younger than 70 years

artículo científico publicado en 2012

Risk identification of osteoporosis in postmenopausal women by a simple algorithm based on ultrasound densitometry and body mass index

artículo científico publicado en 2008

The Xmas present for women's health: a strike to osteoporosis prevention

artículo científico publicado en 2004

The latest elaboration of the Women's Health Initiative data on hormone replacement therapy and cardiovascular disease in postmenopausal women

artículo científico publicado en 2007

The osteoporosis dilemma

artículo científico publicado en 2004

The return of hormonal therapy.

artículo científico publicado en 2007

The sound of an International anti-HRT herald ⬇️

artículo científico publicado el 20 de octubre de 2003

Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women

artículo científico publicado en 2007

Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors

artículo científico publicado en 2017

Vasomotor symptoms and negative affect: time to act.

artículo científico publicado en 2011

[Management of cardiovascular risk in the peri-menopausal woman--a consensus statement of European cardiologists and gynaecologists]

artículo científico publicado en 2007

Lista de obras de

"Controversial issues in climacteric medicine" series 3rd Pisa workshop "HRT in climacteric and aging brain". Pisa, Italy, 15-18 March 2003.

Clinical relevance of the HERS trial

Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome

Contraception with estradiol valerate and dienogest: adherence to the method.

Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.

Dydrogesterone does not reverse the effects of estradiol on endothelium-dependant vasodilation in postmenopausal women: a randomised clinical trial.

EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis

EMAS position statement: Bone densitometry screening for osteoporosis

EMAS position statement: Managing menopausal women with a personal or family history of VTE.

EMAS position statement: Managing the menopause in the context of coronary heart disease

EMAS position statement: Managing the menopause in women with a past history of endometriosis

EMAS position statement: Managing women with premature ovarian failure

EMAS position statement: Vitamin D and postmenopausal health

EMAS position statement: managing obese postmenopausal women

EMAS position statement: managing the menopause in women with epilepsy

Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention

Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution

Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women.

Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women

Effects of oral contraceptives on bone mineral density.

Erratum to “EMAS position statement: Bone densitometry screening for osteoporosis” [Maturitas 68 (2011) 98–101]

Erratum to “EMAS position statement: Managing obese postmenopausal women” [Maturitas 66 (2010) 323–326]

Erratum to “EMAS position statement: Managing the menopause in the context of coronary heart disease” [Maturitas 68 (2011) 94–97]

Erratum to “EMAS position statement: Managing the menopause in women with epilepsy” [Maturitas 66 (2010) 327–328]

Erratum to “EMAS position statement: Managing women with premature ovarian failure” [Maturitas 67 (2010) 91–93]

From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health

Homocysteine, menopause and cardiovascular disease

Hormonal influence on the central nervous system

Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women

Hormone replacement therapy and the prevention of postmenopausal osteoporosis

Hormone therapy

IMS updated recommendations on postmenopausal hormone therapy

Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.

Laser therapy for the restoration of vaginal function

Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density

Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists

Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society

New HRT options for the treatment of menopausal symptoms and the maintenance of quality of life in postmenopausal women

Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper

Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate

Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy.

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Practical recommendations for hormone replacement therapy in the peri- and postmenopause

Progesterone to treat vasomotor symptoms

Quantitative ultrasound (QUS) of bone in the management of postmenopausal women

Recommendations on the management of fragility fracture risk in women younger than 70 years

Risk identification of osteoporosis in postmenopausal women by a simple algorithm based on ultrasound densitometry and body mass index

The Xmas present for women's health: a strike to osteoporosis prevention

The latest elaboration of the Women's Health Initiative data on hormone replacement therapy and cardiovascular disease in postmenopausal women

The osteoporosis dilemma

The return of hormonal therapy.

The sound of an International anti-HRT herald ⬇️

Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women

Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors

Vasomotor symptoms and negative affect: time to act.

[Management of cardiovascular risk in the peri-menopausal woman--a consensus statement of European cardiologists and gynaecologists]